Search - tctmd.com

Displaying 241 - 254 of 254

Sort: Relevancy | Date

News Daily News

Se Publica el TARGET-CABG: El Período de Espera al CABG depende de la Prueba de la Función Plaquetaria

Yael L. Maxwell

March 15, 2012

News Daily News

Análisis PLATO: Los IBP son Problemáticos tanto con el Ticagrelor como con el Clopidogrel

March 06, 2012

News Industry News

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

December 07, 2011

News Daily News

Hospital Readmission Post-PCI Linked to Increased Mortality

Yael L. Maxwell

December 05, 2011

News Industry News

Cangrelor provides effective maintenance of platelet inhibition without major bleeding for patients who require bypass surgery

November 08, 2011

News Daily News

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

May 02, 2011

The Role of Atrial Shunts in the Treatment of HFpEF

CME

The Role of Atrial Shunts in the Treatment of HFpEF

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

CME

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

PLX Pharma - Aspirin for the Interventionalist: More Than Meets the Eye

CME

Aspirin for the Interventionalist: More Than Meets the Eye

Changing Course with Anticoagulation in Secondary Prevention of CAD

CME

Changing Course with Anticoagulation in Secondary Prevention of CAD

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

CME

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

CME

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.